TCL Archive ODAC Supports Approval For Taxotere In Breast Cancer, Hycamtin In Lung Cancer June 5, 1998
TCL Archive Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease November 30, 2012